<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To evaluate the genetic, congenital and <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> which were detected concurrently with <z:e sem="disease" ids="C0206663" disease_type="Neoplastic Process" abbrv="CPNET">primitive neuroectodermal tumors (PNET)</z:e> of the central <z:mp ids='MP_0008912'>nervous</z:mp> system in children </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Medical records of 1030 children who were admitted to our department with diagnosis of <z:mp ids='MP_0009277'>brain tumor</z:mp> between 1975 and 2005 were reviewed retrospectively </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0002885'>Medulloblastoma</z:hpo> and <z:e sem="disease" ids="C1336538" disease_type="Neoplastic Process" abbrv="">supratentorial PNETs</z:e> were detected in 289 patients </plain></SENT>
<SENT sid="3" pm="."><plain>They were reviewed for associated metabolic conditions, genetic and congenital defects </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: One of the following conditions were detected in 10 patients with <z:hpo ids='HP_0002885'>medulloblastoma</z:hpo> and <z:e sem="disease" ids="C1336538" disease_type="Neoplastic Process" abbrv="">supratentorial PNETs</z:e>: <z:hpo ids='HP_0001067'>Neurofibromatosis</z:hpo> type 1, <z:e sem="disease" ids="C0004779,C0812437" disease_type="Disease or Syndrome;Neoplastic Process" abbrv="">Gorlin syndrome</z:e>, <z:e sem="disease" ids="C0345893" disease_type="Neoplastic Process" abbrv="JPS|JIP|PJI">juvenile polyposis</z:e> coli, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prone syndrome of total <z:hpo ids='HP_0200024'>premature chromatid separation</z:hpo> and Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo>, bilateral <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo>, L-2-hydroxyglutaric <z:hpo ids='HP_0012072'>aciduria</z:hpo>, <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert syndrome</z:e>, <z:e sem="disease" ids="C0272302" disease_type="Disease or Syndrome" abbrv="GPS">gray platelet syndrome</z:e>, <z:mp ids='MP_0005170'>cleft lip</z:mp>-palate and left <z:hpo ids='HP_0000104'>renal agenesis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In the patients with multiple malignant diseases, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prone syndrome of total <z:hpo ids='HP_0200024'>premature chromatid separation</z:hpo> and Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo>, <z:e sem="disease" ids="C0004779,C0812437" disease_type="Disease or Syndrome;Neoplastic Process" abbrv="">Gorlin syndrome</z:e> and <z:e sem="disease" ids="C0345893" disease_type="Neoplastic Process" abbrv="JPS|JIP|PJI">juvenile polyposis</z:e> coli were diagnosed after diagnosis of the <z:mp ids='MP_0002018'>malignant tumors</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0002885'>Medulloblastoma</z:hpo> was the first manifestation in the case with <z:e sem="disease" ids="C0004779,C0812437" disease_type="Disease or Syndrome;Neoplastic Process" abbrv="">Gorlin syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In case with <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo>, <z:e sem="disease" ids="C0205898" disease_type="Neoplastic Process" abbrv="">pineal PNET</z:e> was detected 2 months after diagnosis of <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain><z:mp ids='MP_0005170'>Cleft lip</z:mp>-palate and L-2-Hydroxyglutaric <z:hpo ids='HP_0012072'>aciduria</z:hpo> were detected previously in the patients before their <z:mp ids='MP_0009277'>brain tumors</z:mp> whereas Gray platelet, <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert syndrome</z:e> and left <z:hpo ids='HP_0000104'>renal agenesis</z:hpo> were diagnosed during treatment of <z:hpo ids='HP_0002885'>medulloblastoma</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Associated genetic, metabolic and congenital conditions were detected in 3.5% of the cases </plain></SENT>
<SENT sid="10" pm="."><plain>Thus the patients with PNET should be followed for these defects </plain></SENT>
</text></document>